Charles Schwab Investment Management Inc. lifted its position in shares of DocuSign, Inc. (NASDAQ:DOCU – Free Report) by 1.0% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,341,953 shares of the company’s stock after acquiring an additional 13,598 shares during the quarter. Charles Schwab Investment Management Inc. owned 0.66% of DocuSign worth $120,695,000 as of its most recent SEC filing.
A number of other institutional investors have also recently modified their holdings of DOCU. Synergy Financial Group LTD boosted its position in DocuSign by 3.4% during the fourth quarter. Synergy Financial Group LTD now owns 4,241 shares of the company’s stock worth $381,000 after purchasing an additional 140 shares in the last quarter. Avior Wealth Management LLC lifted its position in shares of DocuSign by 36.5% during the 4th quarter. Avior Wealth Management LLC now owns 542 shares of the company’s stock valued at $49,000 after buying an additional 145 shares in the last quarter. Linden Thomas Advisory Services LLC lifted its position in shares of DocuSign by 1.1% during the 4th quarter. Linden Thomas Advisory Services LLC now owns 13,540 shares of the company’s stock valued at $1,218,000 after buying an additional 149 shares in the last quarter. Optimist Retirement Group LLC grew its stake in DocuSign by 3.8% in the 3rd quarter. Optimist Retirement Group LLC now owns 4,416 shares of the company’s stock valued at $274,000 after acquiring an additional 161 shares during the period. Finally, Covestor Ltd raised its position in DocuSign by 5.8% during the third quarter. Covestor Ltd now owns 3,306 shares of the company’s stock worth $205,000 after acquiring an additional 182 shares during the period. 77.64% of the stock is currently owned by institutional investors and hedge funds.
Wall Street Analyst Weigh In
Several analysts have recently issued reports on the stock. Hsbc Global Res upgraded shares of DocuSign to a “moderate sell” rating in a research report on Friday, December 6th. HSBC reiterated a “reduce” rating on shares of DocuSign in a report on Friday, December 6th. Morgan Stanley raised their target price on DocuSign from $62.00 to $97.00 and gave the company an “equal weight” rating in a research report on Friday, December 6th. JPMorgan Chase & Co. boosted their price target on DocuSign from $50.00 to $70.00 and gave the stock an “underweight” rating in a research report on Tuesday, December 3rd. Finally, Wells Fargo & Company raised their price objective on DocuSign from $50.00 to $70.00 and gave the company an “underweight” rating in a report on Friday, December 6th. Three investment analysts have rated the stock with a sell rating, seven have given a hold rating and three have issued a buy rating to the company. According to MarketBeat.com, the company currently has an average rating of “Hold” and a consensus target price of $92.45.
Insider Transactions at DocuSign
In other DocuSign news, CEO Allan C. Thygesen sold 40,000 shares of the stock in a transaction dated Thursday, January 2nd. The shares were sold at an average price of $90.04, for a total transaction of $3,601,600.00. Following the completion of the transaction, the chief executive officer now owns 156,050 shares of the company’s stock, valued at $14,050,742. This trade represents a 20.40 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director Teresa Briggs sold 534 shares of the business’s stock in a transaction that occurred on Monday, December 16th. The shares were sold at an average price of $94.60, for a total value of $50,516.40. Following the completion of the sale, the director now directly owns 7,736 shares in the company, valued at approximately $731,825.60. The trade was a 6.46 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 686,010 shares of company stock worth $66,102,694 in the last 90 days. Insiders own 1.66% of the company’s stock.
DocuSign Trading Up 0.1 %
DocuSign stock opened at $79.83 on Friday. The stock has a market cap of $16.13 billion, a P/E ratio of 16.46, a PEG ratio of 6.94 and a beta of 1.02. The company has a 50-day moving average price of $89.05 and a 200 day moving average price of $78.60. DocuSign, Inc. has a 12-month low of $48.70 and a 12-month high of $107.86.
DocuSign Company Profile
DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.
See Also
- Five stocks we like better than DocuSign
- What is a buyback in stocks? A comprehensive guide for investors
- These 4 Tech ETFs Just Hit 50-Day Lows—Time to Buy?
- The How And Why of Investing in Oil Stocks
- 3 Stocks to Buy While Others Stay on the Sidelines
- Quiet Period Expirations Explained
- MarketBeat Week in Review – 03/03 – 03/07
Want to see what other hedge funds are holding DOCU? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DocuSign, Inc. (NASDAQ:DOCU – Free Report).
Receive News & Ratings for DocuSign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocuSign and related companies with MarketBeat.com's FREE daily email newsletter.